Re my wife's connection . The head of her Renal Dept asks her to screen patients for clinical trials. So over the years she has recruited patients for FGEN trials and PRTO.
Regarding PRTO ...her view from memory ....one of the top vascular surgeons at her hospital is in charge of the trial here.
Will not need to show an enormous improvement to be clinically meaningful ...and apparently its low cost ...$400-$600 per fistula .
Time from AVF creation to abandonment is the key end pt ...correct ?
I have just a small long position and have not paid much attention to it since the head of her Dept started gushing over the Avenu Medical system ....but will chk in with her again based on the guideline information you posted .
thx
Kiwi
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM